ArticleScientific reports2018

Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes.

Kwong-Man Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.